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nterest in our recent paper (1).
We agree with Dr. Mozafarrian that many of the prevalent
ealth problems afflicting modernized societies result from dietary
nd lifestyle factors that are at odds with the evolutionary milieu
or which we remain genetically adapted. Mounting worldwide
eficiencies of fresh vegetables and fruits, outdoor exercise,
mega-3 fatty acids, and vitamin D are all rooted in this funda-
ental displacement from our natural outdoor environment to an
ndoor sedentary lifestyle with a synthetic, highly processed,
alorie-dense, nutritionally barren diet (2). The intuitive solution is
o simulate that natural human diet and lifestyle to the extent that
his is possible and practically achievable (3). Notwithstanding,
any individuals may need daily supplements of vitamin D andmega-3 fats.Dr. Mozafarrian questions whether the apparent cardiovascular
CV) benefits associated with higher vitamin D levels might be
onfounded by outdoor physical and social activities that will
oncomitantly increase vitamin D levels and reduce CV risk. To be
ure, exercise confers powerful CV protection, and some evidence
uggests that physical activity performed outside may be more
eneficial than indoor exercise (4). Indeed, vitamin D produced in
esponse to sun exposure maintains serum 25-hydroxyvitamin D
25(OH)D] levels longer than orally ingested vitamin D (5). Yet
tudies indicate that vitamin D synthesis in response to sunlight is
ighly variable depending on geographic location and season and
n skin pigmentation. Even in locales with abundant sun exposure,
uch as Hawaii and southern Arizona, over 50% of inhabitants
ave been documented to be vitamin-D deficient (6,7). Moreover,
xcessive sunlight exposure in the times and locales characterized
y intense ultraviolet radiation can predispose to skin cancers and
remature skin aging, especially for individuals not genetically
dapted (darker skin pigmentation) for equatorial climates. Thus,
ogical and effective strategies for maintaining normal vitamin D
evels include safe sun exposure (15 to 20 min of daily unprotected
unlight exposure of arms and legs 3 times per week in the spring,
ummer, and fall), and oral vitamin D supplementation. The
efinitions of deficient, normal, and ideal vitamin D levels remain
ontroversial. A target level for 25(OH)D of 30 to 60 ng/ml is safe
nd reasonable based on current data. Most studies indicate that
pward of 50% of Americans have vitamin D 25(OH)D levels
elow 30 ng/ml, which can predispose to many CV problems,
ncluding statin-related myalgias (8).
The safety and efficacy of vitamin D supplementation for
mproving CV health will need to be established with large
andomized controlled clinical trials. Generally, nutritional sup-
lements, when tested in large randomized controlled trials, have
ot improved clinical outcomes. However, 2 notable exceptions
xist: omega-3 and vitamin D. It is likely not coincidental that
hese same 2 essential nutrients are the ones most likely to be
eficient among the American population (3,9). The quantity and
uality of supportive randomized trial data for omega-3 exceeds
hat for vitamin D. Even so, the randomized controlled vitamin D
rials performed to date have shown reductions in total mortality
10), fractures (11), and falls (12) when daily doses of 800 IU
itamin D were used.
Drs. Pilz and Tomaschitz highlight the growing body of
vidence indicating that vitamin D deficiency adversely affects
yocardial function and structure. This almost certainly contrib-
tes to the apparent CV toxicity of vitamin D deficiency.
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